The cytokine and histological response in islet xenograft rejection is dependent upon species combination

被引:27
作者
Medbury, HJ
Hibbins, M
Lehnert, AM
Hawthorne, WJ
Chapman, JR
Mandel, TE
OConnell, PJ
机构
[1] WESTMEAD HOSP,NATL PANCREAS TRANSPLANT UNIT,WESTMEAD,NSW 2145,AUSTRALIA
[2] WESTMEAD HOSP,DEPT SURG,WESTMEAD,NSW 2145,AUSTRALIA
[3] WALTER & ELIZA HALL INST MED RES,TRANSPLANTAT UNIT,PARKVILLE,VIC,AUSTRALIA
关键词
D O I
10.1097/00007890-199711150-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Islet xenografts have clinical potential, may avoid hyperacute rejection, and therefore are a good place to examine the cellular xenograft immune response. The aim of this study was to examine the cellular, humoral, and cytokine response in islet xenograft rejection and to determine the difference in the immune response with a different donor species. Methods. Two islet xenograft models (DA rat islets to B6AF(1), mouse and canine islets to B6AF(1), mouse) and a mouse syngeneic control model were examined histologically and by a semiquantitative polymerase chain reaction method, Results. There was significant up-regulation of all intragraft cytokines tested (interleukin [IL]-2, IL-4, IL-5, IL-10, and interferon-gamma) in both xenograft models compared with the controls, However, the dog islet grafts had higher levels of IL-4 and IL-5 gene expression than the rat islet grafts, which, conversely, had higher levels of interferon-gamma gene expression. These differences correlated with the histological and anti-donor antibody production differences between the two models. The dog to mouse model had an intense eosinophilic infiltrate and an early up-regulation of anti-donor antibody, whereas there was little eosinophilic infiltrate and a delayed anti-donor antibody upregulation in the rat to mouse model, Conclusions, The mouse used different mechanisms to reject the rat and canine islets, suggesting that the immune response in islet xenograft rejection may be dependent on the species combination, It may not be possible to characterize the cellular xenograft rejection response in a bipolar manner as has been the case with humoral rejection response, Caution therefore needs to be taken before extrapolating the cellular immune responses seen in animal models to the clinical setting.
引用
收藏
页码:1307 / 1314
页数:8
相关论文
共 41 条
[1]   ACTIVATION AND FUNCTIONS OF CD4+ T-CELL SUBSETS [J].
ABBAS, AK ;
WILLIAMS, ME ;
BURSTEIN, HJ ;
CHANG, TL ;
BOSSU, P ;
LICHTMAN, AH .
IMMUNOLOGICAL REVIEWS, 1991, 123 :5-22
[2]   CELLULAR BASIS OF THE PROLIFERATIVE RESPONSE OF HUMAN T-CELLS TO MOUSE XENOANTIGENS [J].
ALTER, BJ ;
BACH, FH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) :333-338
[3]  
ANDERSSON A, 1992, TRANSPLANT P, V24, P677
[4]   INTERLEUKIN-5 MESSENGER-RNA EXPRESSION BY EOSINOPHILS IN THE INTESTINAL-MUCOSA OF PATIENTS WITH CELIAC-DISEASE [J].
DESREUMAUX, P ;
JANIN, A ;
COLOMBEL, JF ;
PRIN, L ;
PLUMAS, J ;
EMILIE, D ;
TORPIER, G ;
CAPRON, A ;
CAPRON, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01) :293-296
[5]   ROLE OF ANTIGEN-PRESENTING CELLS IN THE POLARIZED DEVELOPMENT OF HELPER T-CELL SUBSETS - EVIDENCE FOR DIFFERENTIAL CYTOKINE PRODUCTION BY TH0 CELLS IN RESPONSE TO ANTIGEN PRESENTATION BY B-CELLS AND MACROPHAGES [J].
DUNCAN, DD ;
SWAIN, SL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2506-2514
[6]   EFFECTS OF INTERLEUKIN-12 ON IMMUNE-RESPONSES AND HOST PROTECTION IN MICE INFECTED WITH INTESTINAL NEMATODE PARASITES [J].
FINKELMAN, FD ;
MADDEN, KB ;
CHEEVER, AW ;
KATONA, IM ;
MORRIS, SC ;
GATELY, MK ;
HUBBARD, BR ;
GAUSE, WC ;
URBAN, JF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1563-1572
[7]  
Fitch Frank W., 1993, P733
[8]  
FITCH FW, 1993, ANNU REV IMMUNOL, V11, P29, DOI 10.1146/annurev.immunol.11.1.29
[9]   B7-1 AND B7-2 DO NOT DELIVER IDENTICAL COSTIMULATORY SIGNALS, SINCE B7-2 BUT NOT B7-1 PREFERENTIALLY COSTIMULATES THE INITIAL PRODUCTION OF IL-4 [J].
FREEMAN, GJ ;
BOUSSIOTIS, VA ;
ANUMANTHAN, A ;
BERNSTEIN, GM ;
KE, XY ;
RENNERT, PD ;
GRAY, GS ;
GRIBBEN, JG ;
NADLER, LM .
IMMUNITY, 1995, 2 (05) :523-532
[10]  
GAJEWSKI TF, 1991, J IMMUNOL, V146, P1750